Corium - 4 Year Stock Split History | CORI

Stock split history for Corium since 2014. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Corium Annual Stock Splits
Corium Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.456B $0.032B
Corium International, Inc. is a commercial-stage biopharmaceutical company. It is focused on the development, manufacture and commercialization of specialty pharmaceutical products that leverage advanced technologies in transdermal and transmucosal delivery systems. Corium has developed six marketed products in the prescription drug and consumer markets: Clonidine Transdermal Delivery System for hypertension, Fentanyl TDS for chronic pain and four Crest Advanced Seal Whitestrips products. The company has two proprietary transdermal technology platforms with applications in multiple drug categories and indications: Corplex(TM) and MicroCor(R). Corium International, Inc. is headquartered in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $64.118B 11.00
Teva Pharmaceutical Industries (TEVA) Israel $21.629B 6.04
Mylan (MYL) United Kingdom $16.715B 7.11
Bausch Health Cos (BHC) Canada $8.595B 6.40
Dr Reddy's Laboratories (RDY) India $5.663B 25.30
Supernus Pharmaceuticals (SUPN) United States $2.502B 26.76
Mallinckrodt Public Limited Company (MNK) United Kingdom $2.263B 3.85
Akorn (AKRX) United States $0.878B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.866B 124.87
Homology Medicines (FIXX) United States $0.751B 0.00
CymaBay Therapeutics (CBAY) United States $0.638B 0.00
Assembly Biosciences (ASMB) United States $0.629B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.496B 0.00
Voyager Therapeutics (VYGR) United States $0.491B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.488B 0.00
Teligent (TLGT) United States $0.183B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.128B 0.00
Sol-Gel Technologies (SLGL) Israel $0.125B 0.00
Aevi Genomic Medicine (GNMX) United States $0.074B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.063B 0.00
Evoke Pharma (EVOK) United States $0.043B 0.00
Acasti Pharma (ACST) Canada $0.042B 0.00
Agile Therapeutics (AGRX) United States $0.029B 0.00
China Pharma Holdings (CPHI) China $0.020B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.010B 0.00